{
    "clinical_study": {
        "@rank": "119440", 
        "acronym": "HALO", 
        "arm_group": {
            "arm_group_label": "Non-Dysplastic IM, LGD, HGD"
        }, 
        "biospec_descr": {
            "textblock": "Serum from Biopsy"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to provide a tool for physicians to compare outcome data\n      related to the use of the HALO Ablation Systems.  This study is a single-center patient\n      registry which will contribute to a framework for treatment and follow-up of patients with\n      Barrett's  Esophagus."
        }, 
        "brief_title": "Patient Registry: Radio Frequency Ablation of Barrett's Esophagus Using HALO System", 
        "condition": "Barrett's Esophagus", 
        "condition_browse": {
            "mesh_term": "Barrett Esophagus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  candidate for ablation of Barrett's Esophagus with the HALO Ablation System\n             (Prospective)\n\n          -  received an ablation with the HALO Ablation System to treat Barrett's Esophagus\n             (Retrospective)\n\n          -  candidate agrees to proposed follow-up schedule of yearly surveillance following\n             treatment\n\n          -  signs consent\n\n        Exclusion Criteria:\n\n          -  has not been diagnosed with Barrett's Esophagus"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult patients presenting with esophageal intestinal metaplasia (IM), including  the\n        pathological subclasses of non-dysplastic IM, low-grade dysplasia (LGD) and high-grade\n        dysplasia (HGD)"
            }
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033070", 
            "org_study_id": "Barrett's RFA"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "RFA", 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kenner", 
                    "country": "United States", 
                    "state": "Louisiana"
                }, 
                "name": "Ochsner Medical Center"
            }, 
            "status": "Active, not recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Single Center Patient Registry Using Radio Frequency Ablation of Barrett's Esophagus Using HALO System", 
        "other_outcome": {
            "measure": "Histological clearance rate for dysplasia", 
            "safety_issue": "No", 
            "time_frame": "Biopsy taken at 12 months to determine effectiveness"
        }, 
        "overall_official": {
            "affiliation": "Oshsner Clinic Foundation and Medical Center-Kenner", 
            "last_name": "Virendra Joshi, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Endoscopic clearance rate for Barrett's Esophagus", 
            "safety_issue": "No", 
            "time_frame": "Outcome measure is assessed at Month 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033070"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ochsner Health System", 
            "investigator_full_name": "Virendra Joshi", 
            "investigator_title": "Virendra Joshi, MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Histological clearance rate for intestinal metaplasia", 
            "safety_issue": "No", 
            "time_frame": "Biopsy taken at 12 months"
        }, 
        "source": "Ochsner Health System", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ochsner Health System", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Years", 
        "verification_date": "January 2014"
    }
}